Skip to main content
Fig. 3 | Cancer Nanotechnology

Fig. 3

From: Excretable, ultrasmall hexagonal NaGdF4:Yb50% nanoparticles for bimodal imaging and radiosensitization

Fig. 3

Biocompatibility of H2O-dispersed β-NaGdF4:Yb50%: a ICP-OES analysis of the Gd3+ ions leaching from the nanoparticles after 3 days of dialysis. b Cell viability when incubated with the nanoparticles evaluated by the MTS assay. c Biodistribution at 4 h post-injection via tail vein measured by ICP-MS. d Cumulative renal and fecal clearance of the nanoparticles monitored by Gd3+ determination via ICP-MS

Back to article page

Cancer Nanotechnology

ISSN: 1868-6966

Contact us